STAND. COM. REP. NO.2012
RE: S.B. No. 2089
Honorable Robert Bunda
President of the Senate
Twenty-First State Legislature
Regular Session of 2002
State of Hawaii
Your Committee on Health and Human Services, to which was referred S.B. No. 2089 entitled:
"A BILL FOR AN ACT RELATING TO REGULATION OF PRESCRIPTIVE AUTHORITY OVER CONTROLLED SUBSTANCES,"
begs leave to report as follows:
The purpose of this measure, as received, is to create a controlled substance panel within the Department of Health to regulate prescriptive authority.
Testimony in support of this measure was submitted by the Department of Health, Hawaii Medical Association, and Department of Public Safety. Testimony in opposition to this measure was submitted by the Hawaii Nurses' Association, University of Hawaii, John A. Burns School of Medicine, and three private individuals. The Hawaii Dental Association submitted comments on this measure.
Your Committee finds that there is a mechanism needed to assure that expansion of prescriptive authority is given only when the benefit to the population is clear and a detailed assessment on the impact has been made. Your Committee further finds that expansion of prescriptive authority is a complex issue, and careful consideration is needed to assure public safety. Therefore, your Committee has amended this measure by deleting its contents and replacing it with a requirement that the Legislative Reference Bureau conduct an impact assessment report before prescriptive authority can be expanded.
As affirmed by the record of votes of the members of your Committee on Health and Human Services that is attached to this report, your Committee is in accord with the intent and purpose of S.B. No. 2089, as amended herein, and recommends that it pass Second Reading in the form attached hereto as S.B. No. 2089, S.D. 1, and be referred to the Committee on Commerce, Consumer Protection and Housing.
Respectfully submitted on behalf of the members of the Committee on Health and Human Services,
DAVID MATSUURA, Chair